<![CDATA[
<p style="font: 12px/19px gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="color: red; font-size: 16pt;">종근당(185750)<span style="font-size: 11pt;">제약주 시세가 마무리 되고 자회사 상장이라는 호재가 소멸되면서 주가가 급락했는데 이제는 서서히 반등을 기대</span><span style="font-size: 11pt;">해 볼만하다. 최근 주가하락의 이유는 </span><font color="#000000"><span style="font-size: 11pt;">종근당의 신약 후보물질을 도입해 임상시험을 진행 중인 미국 제약사의 주가가 급락했다는 소식이 전해졌기 때문이다. </span></font></span></p><p style="font: 12px/19px gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="color: red; font-size: 16pt;"><font color="#000000"><span style="font-size: 11pt;">종근당의 벨로라닙 임상을 진행 중인 미국 자프겐(Zafgen)은 임상 중 사망자가 발생해 FDA(미국식품의약국)로부터 명령을 받아 일부 임상이
중단됐다</span></font></span></p><p style="font: 12px/19px gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="color: red; font-size: 16pt;"><font color="#000000"></font></span> </p><p style="font: 12px/19px gulim; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0px; margin-right: 0px; margin-bottom: 0px; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="color: rgb(0, 0, 0); font-size: 11pt;">흘러내리던 주가가 이런 악재가 노출되면서 주가가 급락하면 손바뀜현상으로 주가가 상승전환되는 경우가 많은데 종근당은 최근 4일째 양봉을 만들어 내고 있다. 수직상승은 어려워 보이나 추격매도 구간은 아니라 판단된다. </span></p><p style="font: 12px/19px gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"> </p><p style="font: 12px/19px gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><strong></strong> </p><p style="font: 12px/19px gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><strong>*7만원선까지 반등은 기대해 볼 수있다. </strong></p><p style="font: 12px/19px gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"> </p><p style="font: 12px/19px gulim; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0px; margin-right: 0px; margin-bottom: 0px; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="color: red; font-size: 16pt;"><font color="#000000"><span style="font-size: 11pt;">종근당은 2013년 11월 2일을 분할기준일로 </span><span style="font-size: 11pt;">투자사업부문을 담당하는 존속법인 (주)종근당홀딩스와 의약품사업부문을 담당하는 신설회사인 (주)종근당으로 </span><span style="font-size: 11pt;">인적분할되어 설립되었습니다.</span></font></span></p><p style="font: 12px/19px gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="font-size: 11pt;"> </span><span style="font-size: 11pt;"> </span></p><p style="font: 12px/19px gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="font-size: 11pt;"> </span></p><p style="font: 12px/19px gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"> </p><p style="font: 12px/19px gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="color: red; font-size: 16pt;">읽고나면 추천 꾹~!</span></p><p style="font: 12px/19px gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"> </p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="color: red;">*</span><span style="color: red;">요약재무제표</span></p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="font-family: gulim, serif; font-size: 9pt;"> </span></p><p><table style="font: 12px/19px gulim; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" class="MsoTableGrid" border="1" cellSpacing="0" cellPadding="0"><tbody><tr><td style="padding: 0cm 5.4pt; border: 1pt solid windowtext; width: 461.2pt; color: rgb(0, 0, 0); line-height: 1.6; font-family: gulim; font-size: 9pt;" vAlign="top" width="615"><p style="margin: 0px; padding: 0px; line-height: 14.4pt;" align="left"><span style="font-family: gulim, serif; font-size: 9pt;">14년 성장에 이어 15년 1분기 영업이익은 소폭 감소를 기록했다.</span></p><p style="margin: 0px; padding: 0px; line-height: 14.4pt;" align="left"> </p><p style="margin: 0px; padding: 0px; text-align: left; line-height: 14.4pt;"><img style="clear: none; float: none;" id="tx_entry_98606_" class="txc-image" border="0" hspace="1" vspace="1" src="https://t1.daumcdn.net/cfile/cafe/220EE43E5559A16A01" width="392" data-filename="1.jpg" exif="{}" actualwidth="392" id="A_220EE43E5559A16A016EF2"/></p><p style="margin: 0px; padding: 0px; text-align: left; line-height: 14.4pt;"> </p><p style="margin: 0px; padding: 0px; text-align: left; line-height: 14.4pt;">부채비율, 유동비율에 큰 변화없이 안정적 흐름 보여주고 있다. </p><p style="margin: 0px; padding: 0px; text-align: left; line-height: 14.4pt;"> </p><p style="margin: 0px; padding: 0px; line-height: 14.4pt;" align="left"></p></td></tr></tbody></table><p> </p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="font-family: gulim, serif; font-size: 9pt;"> </span></p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="font-family: gulim, serif; font-size: 9pt;"> </span></p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="font-family: gulim, serif; font-size: 9pt;"><a style="color: rgb(0, 0, 0); text-decoration: none; border-bottom-color: rgb(132, 0, 0); border-bottom-width: 1px; border-bottom-style: dashed;" href="http://cafe.daum.net/_c21_/bbs_list?grpid=5HIJ&fldid=Lcnu" target="_blank"><b><span style="color: rgb(9, 0, 255); font-family: 굴림; font-size: 14.5pt;"><span>시장을 </span></span></b><b><span style="color: rgb(9, 0, 255); font-family: 굴림; font-size: 14.5pt;"><span>뒤흔들 </span></span></b><b><span style="color: rgb(9, 0, 255); font-family: 굴림; font-size: 14.5pt;"><span>테마주 </span></span></b><b><span style="color: rgb(9, 0, 255); font-family: 굴림; font-size: 14.5pt;"><span>미리보기☞</span></span></b></a></span></p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><b></b> </p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><b><span style="color: red; font-size: 12pt;">@</span></b><b><span style="color: red; font-size: 12pt;">요약<span>—신약개발 악재로 주가하락 </span></span></b></p><p><table style="font: 12px/19px gulim; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" border="1" cellSpacing="0" cellPadding="0" table?=""><tbody><tr><td style="background: rgb(214, 227, 188); border-width: 1pt 1pt 3pt; border-style: solid; border-color: white; padding: 0cm 5.4pt; width: 461.2pt; color: rgb(0, 0, 0); line-height: 1.6; font-family: gulim; font-size: 9pt;" vAlign="top" width="615"><p style="margin: 0px; padding: 0px;" align="left"><b><span style="color: black;"> </span></b></p><p style="margin: 0px; padding: 0px;" align="left"><span style="color: black;"><strong><span style="font-size: 11pt;">고도비만 치료제 </span></strong><span style="font-size: 11pt;">'CKD-732' 임상이 순조롭게 진행되고 있다. 최근 제약업체의 신약관련 급등이 자주 나타나고 있다. </span></span></p><p style="margin: 0px; padding: 0px;" align="left"> </p><p style="margin: 0px; padding: 0px;" align="left"> </p><p><span style="font-size: 11pt;">“미국 자프겐(Zafgen)사는 현재 종근당의 고도비만 치료제 ‘CKD-732’와 ‘ZGN-839’의 개발을 맡고 있다</span></p><p> </p><p><span style="font-size: 11pt;">“미국에서만 고도비만 환자가 1700만명에 달할 정도로 시장이 크다. </span></p><p> </p><p><span style="font-size: 11pt;">종근당은 </span><span style="font-size: 11pt;">상위 제약사 대비 신약개발 능력이 낮다는 이유로 항상 저평가 받아왔지만 최근 신약개발이 속속 진행되면서 그런 저평가에서 해소될 가능성이 높다. </span></p><p> </p><p><span style="font-size: 11pt;">*빈혈치료제 </span><span style="font-size: 11pt;">CKD-11101’의 국내임상 3상을 승인 받은점도 긍정적이다. </span></p><p> </p><p><span style="font-size: 11pt;">2세대 빈혈치료제 바이오시밀러로는 국내 최초로 임상3상에 진입한 것이다. </span></p><p> </p><p> </p><p><span style="font-size: 11pt;">그리고 종근당은 인도네시아 제약사인 </span><span style="font-size: 11pt;"> 오토社와 현지법인 ‘CKD-OTTO’ 출범…항암제 생산공장 구축했다.</span></p><p> </p><span style="font-size: 11pt;">이로서 </span><span style="font-size: 11pt;">인도네시아 시장 점유율 확대…아세안 10개국 시장 진출을 위한 교두보 마련하게 된것이다. </span><br><p> </p></td></tr></tbody></table><p> </p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="font-family: gulim, serif; font-size: 9pt;"> </span></p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="font-family: gulim, serif; font-size: 9pt;"> </span></p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><b><span style="color: red; font-size: 12pt;">@</span></b><b><span style="color: red; font-size: 12pt;">사업내용</span></b></p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="color: black; font-family: 돋움; font-size: 9pt;"> </span></p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><b><span style="color: black; font-size: 12pt;"> </span></b></p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="color: black; font-size: 12pt;"><font face="굴림">종근당은 신약 및 개량신약, 제네릭 의약품에 대한 우수한 개발능력을 보유하고 있으며, 연간 매출액 대비 약 13% 이상의 R&D 투자를 진행하고 있습니다</font></span></p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"> </p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"> </p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="color: black; font-size: 12pt;">종근당의 신제품 개발 실적 </span><table border="1" width="604"><colgroup><col width="233"><col width="209"><col width="162"></colgroup><thead><tr><th height="20" width="233" align="middle">제품명</th><th height="20" width="209" align="middle">효능/ 효과</th><th height="20" width="162" align="middle">발매월</th></tr></thead><tbody><tr><td height="20" width="233" align="middle">오프벨라 점안액 </td><td height="20" width="209" align="middle">항생제</td><td height="20" width="162" align="middle">'15년 2월</td></tr><tr><td height="20" width="233" align="middle">레티벨라 연질캡슐</td><td height="20" width="209" align="middle">눈영양제</td><td height="260" rowSpan="9" width="162" align="middle">'15년 3월</td></tr><tr><td height="20" width="233" align="middle">그라벨라 점안액 </td><td height="20" width="209" align="middle">항생제</td></tr><tr><td height="20" width="233" align="middle">올로벨라 점안액 0.1% </td><td height="20" width="209" align="middle">항히스타민제</td></tr><tr><td height="20" width="233" align="middle">옵타벨라 점안액 </td><td height="20" width="209" align="middle">스테로이드</td></tr><tr><td height="20" width="233" align="middle">제노벨라 점안액 0.1%</td><td height="20" width="209" align="middle">안구건조증</td></tr><tr><td height="20" width="233" align="middle">레스타시스 점안액 0.05%</td><td height="20" width="209" align="middle">안구건조증</td></tr><tr><td height="20" width="233" align="middle">릴레스타트 점안액 0.05% </td><td height="20" width="209" align="middle">항히스타민제</td></tr><tr><td height="20" width="233" align="middle">프리락토</td><td height="50" rowSpan="2" width="209" align="middle">유산균 증식,유해균 억제,<br>배변활동 원활</td></tr><tr><td height="20" width="233" align="middle">프리락토 키즈</td></tr></tbody></table><p> </p><p> </p><p> </p><p><strong>@종근당 현재 임상 3상에 진입한 신약은?</strong></p><p><strong>합성신약--신경계 질환 , 수술후 통증완화, 국내임상 3상중.</strong></p><p><strong></strong> </p><p><strong>바이오신약--호흡기계질환(국내임상 2상)</strong></p><p><strong></strong> </p><p><strong>개량신약--심혈관계질환 , 고혈압 치료제 국내 임상 3상 완료</strong></p><p> </p><p>1)일반 의약품</p><p> </p><p style="text-align: center;"><img style="clear: none; float: none;" id="tx_entry_39342_" class="txc-image" border="0" hspace="1" vspace="1" src="https://t1.daumcdn.net/cfile/cafe/2622DB3E5559A5AD14" width="681" data-filename="1.jpg" exif="{}" actualwidth="681" id="A_2622DB3E5559A5AD14D867"/></p><p> </p><p style="text-align: center;"> </p><p> </p><p style="text-align: center;"> </p><p> </p><p>2)전문의약품</p><p><img style="clear: none; float: none;" id="tx_entry_72354_" class="txc-image" border="0" hspace="1" vspace="1" src="https://t1.daumcdn.net/cfile/cafe/223E033E5559A5AE01" width="679" data-filename="1-1.jpg" exif="{}" actualwidth="679" id="A_223E033E5559A5AE013D22"/></p><p> </p><p>3)건강기능식품</p><p> </p><p><img style="clear: none; float: none;" id="tx_entry_95486_" class="txc-image" border="0" hspace="1" vspace="1" src="https://t1.daumcdn.net/cfile/cafe/231A003E5559A5AF19" width="653" data-filename="1-2.jpg" exif="{}" actualwidth="653" id="A_231A003E5559A5AF19DF04"/></p><p><br> </p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"> </p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="color: black; font-size: 12pt;"><strong><font face="굴림">주요 제품 등의 현황<br></font></strong></span><table class="nb" width="623"><colgroup><strong><col width="289"><font face="굴림"></font><col width="334"><font face="굴림"></font></strong></colgroup><tbody><tr><td height="20" vAlign="bottom" width="289" align="right"><strong><br><font face="굴림"></font></strong></td><td height="20" vAlign="bottom" width="334" align="right">(단위 : 백만원, %)</td></tr></tbody></table><table border="1" width="622"><colgroup><col width="61"><col width="66"><col width="108"><col width="214"><col width="99"><col width="74"></colgroup><thead><tr><th height="50" rowSpan="2" width="61" align="middle">사업<br>부문</th><th height="50" rowSpan="2" width="66" align="middle">매출<br>유형</th><th height="50" rowSpan="2" width="108" align="middle">품 목</th><th height="50" rowSpan="2" width="214" align="middle">구체적용도</th><th height="20" width="173" colSpan="2" align="middle">매출 현황</th></tr><tr><th height="20" width="99" align="middle">매출액</th><th height="20" width="74" align="middle">비율</th></tr></thead><tbody><tr><td height="170" rowSpan="6" width="61" align="middle"><br>완제 및<br>원료<br>의약품</td><td height="170" rowSpan="6" width="66" align="middle"><br>제품 및<br>상품</td><td height="20" width="108">타미플루</td><td height="20" width="214">항바이러스제</td><td height="20" width="99" align="right">22,177</td><td height="20" width="74" align="right">15.1%</td></tr><tr><td height="20" vAlign="top" width="108">딜라트렌</td><td height="20" vAlign="top" width="214">고혈압 치료제(베타차단제)</td><td height="20" vAlign="top" width="99" align="right">9,341</td><td height="20" vAlign="top" width="74" align="right">6.3%</td></tr><tr><td height="20" vAlign="top" width="108">리피로우</td><td height="20" vAlign="top" width="214">고지혈증 치료제</td><td height="20" vAlign="top" width="99" align="right">8,014</td><td height="20" vAlign="top" width="74" align="right">5.4%</td></tr><tr><td height="20" vAlign="top" width="108">텔미누보</td><td height="20" vAlign="top" width="214">고혈압 치료제(ARB+CCB)</td><td height="20" vAlign="top" width="99" align="right">4,540</td><td height="20" vAlign="top" width="74" align="right">3.1%</td></tr><tr><td height="20" vAlign="top" width="108">타크로벨</td><td height="20" vAlign="top" width="214">면역억제제</td><td height="20" vAlign="top" width="99" align="right">4,253</td><td height="20" vAlign="top" width="74" align="right">2.9%</td></tr><tr><td height="20" width="108">기 타</td><td height="20" width="214" align="middle">-</td><td height="20" width="99" align="right">98,967</td><td height="20" width="74" align="right">67.2%</td></tr><tr><td height="20" width="61" align="middle">합 계</td><td height="20" width="66" align="middle">-</td><td height="20" width="108" align="middle">-</td><td height="20" width="214" align="middle">-</td><td height="20" vAlign="top" width="99" align="right">147,292</td><td height="20" vAlign="top" width="74" align="right">100.0%</td></tr></tbody></table><p> </p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><b></b> </p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="font-family: gulim, serif; font-size: 9pt;"><b><span style="color: rgb(9, 0, 255); font-family: 굴림; font-size: 14.5pt;"><span><u></u></span></span></b></span> </p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="font-family: gulim, serif; font-size: 9pt;"><b></b></span> </p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="font-family: gulim, serif; font-size: 9pt;"><b></b></span> </p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="font-family: gulim, serif; font-size: 9pt;"><b></b></span> </p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="font-family: gulim, serif; font-size: 9pt;"><b><span style="color: rgb(9, 0, 255); font-family: 굴림; font-size: 14.5pt;"><span><a style="color: rgb(0, 0, 0); text-decoration: none; border-bottom-color: rgb(132, 0, 0); border-bottom-width: 1px; border-bottom-style: dashed;" class="tx-link" href="http://cafe.daum.net/_c21_/bbs_list?grpid=5HIJ&fldid=OTkx" target="_blank"><u><span style="color: rgb(9, 0, 255);">주가에 결정적 정보 무료보기=></span></u></a><u></u></span></span></b></span></p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="color: black; font-family: 돋움; font-size: 9pt;"> </span></p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><b><span style="color: red; font-size: 12pt;">@</span></b><b><span style="color: red; font-size: 12pt;">신규사업 분야</span></b></p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="color: black; font-family: 돋움; font-size: 9pt;"> </span></p><p><table style="font: 12px/19px gulim; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" class="MsoTableGrid" border="1" cellSpacing="0" cellPadding="0"><tbody><tr><td style="padding: 0cm 5.4pt; border: 1pt solid windowtext; width: 461.2pt; color: rgb(0, 0, 0); line-height: 1.6; font-family: gulim; font-size: 9pt;" vAlign="top" width="615"><p style="margin: 0px; padding: 0px; line-height: 14.4pt;" align="left"><span style="font-family: gulim, serif; font-size: 9pt;"><font size="3" face="굴림">고도비만치료제(CKD-732), 표적항암제(CKD-581, 516) 등 다양한 신약개발 임상을 진행 중에 있으며, 특히 CKD-732가 2014년 9월 희귀질환인 '프래더윌리증후군'으로 美 임상3상에 진입하는 성과를 거뒀습니다</font></span></p></td></tr></tbody></table><p><font face="굴림"></font></p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="font-family: gulim, serif; font-size: 9pt;"> </span></p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="font-family: gulim, serif; font-size: 9pt;"> </span></p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><b><span style="color: red; font-size: 12pt;">@</span></b><b><span style="color: red; font-size: 12pt;">관계사 현황</span></b></p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><b><span style="color: black; font-size: 12pt;"> </span></b></p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><b><span style="color: black; font-size: 12pt;"> </span></b></p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><b><span style="color: red; font-size: 12pt;">@</span></b><b><span style="color: red; font-size: 12pt;">투자참고사항</span></b></p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="font-family: gulim, serif; font-size: 9pt;"><a style="color: rgb(0, 0, 0); text-decoration: none; border-bottom-color: rgb(132, 0, 0); border-bottom-width: 1px; border-bottom-style: dashed;" href="http://cafe.daum.net/_c21_/bbs_list?grpid=5HIJ&fldid=OOmd" target="_blank"><b><span style="color: rgb(9, 0, 255); font-family: 굴림; font-size: 14.5pt;"><span>상위 1%</span></span></b><b><span style="color: rgb(9, 0, 255); font-family: 굴림; font-size: 14.5pt;"><span>만 </span></span></b><b><span style="color: rgb(9, 0, 255); font-family: 굴림; font-size: 14.5pt;"><span>아는 </span></span></b><b><span style="color: rgb(9, 0, 255); font-family: 굴림; font-size: 14.5pt;"><span>미노출 </span></span></b><b><span style="color: rgb(9, 0, 255); font-family: 굴림; font-size: 14.5pt;"><span>기업자료 </span></span></b><b><span style="color: rgb(9, 0, 255); font-family: 굴림; font-size: 14.5pt;"><span>보기(</span></span></b><b><span style="color: rgb(9, 0, 255); font-family: 굴림; font-size: 14.5pt;"><span>단독입수)</span></span></b><b><span style="color: rgb(9, 0, 255); font-family: 굴림; font-size: 14.5pt;"><span>☞</span></span></b></a></span></p><p style="font: 12px/14.4pt gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"><span style="color: black;"> </span></p><p style="font: 12px/19px gulim; margin: 0cm 0cm 0pt; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" align="left"></p><p style="font: 12px/19px gulim; margin: 0px; padding: 0px; color: rgb(0, 0, 0); text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;"><span> </span></p><p> </p>
<!-- -->
]]>
카페 게시글
◆게릴라종목분석
종근당--주가를 급락시키는 악재노출. 다음 전망은?
로빈훗
추천 2
조회 688
15.10.19 17:24
댓글 27
다음검색
첫댓글 감사합니다
감사합니다~
감사합니다
감사합니다
좋은 정보 감사합니다
감사합니다
감사합니다
감사합니다
감사합니다.
잘봤습니다^^
감사합니다
감사합니다
감사합니다 ^^
감사합니다
감사합니다
종목 정보 감사합니다
감사합니다.
감사합니다
감사합니다
감사합니다
감사합니다
감사합니다
감사합니다
감사합니다.
고맙습니다^^
감사합니다.
감사합니다